... of providing prescription drug benefits. NAV Fund, an existing investor, joined New Leaf Venture Partners, Tribeca Venture Partners and First Round in Truveris' $12.75 million Series C round, which was led by Canaan Partners. The 5-year-old ...
http://ift.tt/1jV7vQe
http://ift.tt/1jV7vQe
No comments:
Post a Comment